The Metabolic Classroom with Dr. Ben Bikman

In this lecture, Professor Ben Bikman delves into the metabolic aspects of female infertility, specifically focusing on the influence of insulin resistance. He begins by highlighting the high prevalence of infertility among women of reproductive age, with up to 15% affected globally, and particularly prevalent in regions with high rates of insulin resistance, such as Sub-Saharan Africa, South Asia, and the Middle East.

Insulin resistance, a condition where cells become less responsive to insulin, plays a crucial role in female infertility. Dr. Bikman explains that insulin resistance manifests in two main aspects: disrupted insulin signaling in cells and elevated blood insulin levels, known as hyperinsulinemia. These disruptions affect various stages of reproductive physiology, including oocyte development, ovulation, and implantation.

Dr. Bikman then provides a detailed explanation of the ovulatory cycle, emphasizing the interplay of hormones such as follicle-stimulating hormone (FSH), estradiol, and luteinizing hormone (LH) in regulating follicle growth, ovulation, and corpus luteum formation. He discusses how insulin resistance can interfere with this process, leading to poor oocyte quality, failed ovulation, and complications with implantation.

The lecture further explores conditions associated with insulin resistance and female infertility, notably polycystic ovary syndrome (PCOS). Dr. Bikman explains the Rotterdam criteria used for diagnosing PCOS, which include irregular ovulation, signs of hyperandrogenism, and ovarian cysts. He elucidates how insulin resistance contributes to the development of PCOS by inhibiting aromatase activity, leading to reduced estradiol production and disrupted ovulation.

Finally, Dr. Bikman discusses treatment approaches for PCOS, including the use of insulin-sensitizing medications like metformin and dietary interventions such as low-carbohydrate or ketogenic diets. He underscores the importance of addressing insulin resistance to improve ovulatory function and mitigate the most common form of female infertility.

(00:01) Introduction to Female Infertility and Metabolism

(01:14) Global Prevalence of Female Infertility and its Association with Insulin Resistance

(02:23) Understanding Insulin Resistance and its Impact on Female Reproductive Physiology

(05:30) The Ovulatory Cycle and the Role of Hormones in Reproduction

(11:14) Effects of Insulin Resistance on Oocyte Development and Ovulation

(13:27) Impact of Insulin Resistance on Implantation and Uterine Health

(17:19) Polycystic Ovary Syndrome (PCOS) and its Relationship with Insulin Resistance

(33:44) Treatment Approaches for PCOS: Medications and Dietary Interventions

Learn more at https://www.insuliniq.com

#pcos #pcosawareness #PCOSTips #PCOSJourney #PCOSCommunity #PCOSFight #PCOSWarrior #FertilityJourney #InfertilityAwareness #TTC #FertilityTips #FertilitySupport #InfertilitySupport #ConceptionJourney #FertilityTreatment #PCOSandFertility #InfertilityStruggle #PCOSAwarenessMonth #IVF #FertilityHealth #FertilitySuccessStories

Hosted on Acast. See acast.com/privacy for more information.

In this Metabolic Classroom episode, Dr. Bikman delves into the intricate dynamics of fatty liver disease, a prevalent metabolic problem affecting millions worldwide. Describing the liver as the “soccer mom” of metabolism due to its involvement in various metabolic processes, Ben emphasizes the liver’s central role in nutrient metabolism, particularly in handling fats.

Fatty liver disease, once primarily associated with alcohol consumption, has now become a widespread issue driven by metabolic factors. It progresses from simple fat accumulation to inflammation (non-alcoholic steatohepatitis or NASH), fibrosis, and potentially cirrhosis.

Insulin resistance, a key player in metabolic disorders, is dissected into two components: impaired insulin action and chronically elevated insulin levels (hyperinsulinemia). Dr. Bikman highlights the crucial role of insulin in driving fat accumulation in the liver, explaining that elevated insulin is necessary for the liver to store fat and prevent its breakdown, even in the presence of excess free fatty acids. He elucidates how insulin resistance in fat cells leads to increased release of fatty acids, exacerbating fat accumulation in the liver.

Dr. Bikman discusses two primary pathways contributing to fatty liver disease: uptake of free fatty acids from adipose tissue and de novo lipogenesis, the process of synthesizing new fat within the liver.

While elevated insulin primarily drives fat storage, Ben also addresses the independent roles of fructose and alcohol in promoting liver fat accumulation. Fructose metabolism in the liver and alcohol-induced disruptions in fat metabolism contribute significantly to fatty liver disease, even without the direct influence of insulin.

Finally, Dr. Bikman explores strategies for preventing or reversing fatty liver disease, emphasizing the importance of controlling carbohydrate intake to lower insulin levels and restrict fructose consumption. He contrasts pharmaceutical interventions with lifestyle modifications, advocating for dietary changes as a more effective and sustainable approach.

Throughout the Metabolic Classroom lecture, Ben empowers his audience with a deeper understanding of the metabolic underpinnings of fatty liver disease, encouraging them to share this knowledge and take proactive steps toward metabolic health.

#insulinresistance #metabolicsyndrome #metabolichealth #type2diabetes #type1diabetes #weightloss #intermittentfasting #intermittantfasting #fasting #lowcarb 

Learn more at: https://www.insuliniq.com

Hosted on Acast. See acast.com/privacy for more information.

In this lecture from the Metabolic Classroom, Dr. Ben Bikman, a biomedical scientist specializing in metabolism, delves into various strategies for fat loss.

He begins by highlighting the importance of understanding fat tissue dynamics, focusing particularly on hormones, drugs, and sex-specific effects. The main topic for the lecture is strategies for fat loss, which Bikman divides into three categories: drugs, surgical interventions, and lifestyle changes.

Bikman briefly revisits the topic of drugs for fat loss, emphasizing GLP-1 agonists and their mechanism of action in reducing cravings. He discusses their efficacy but also mentions potential side effects such as sexual dysfunction and the risk of regaining fat mass after discontinuation.

Moving on to surgical interventions, Bikman provides detailed explanations of bariatric surgeries including Roux-en-Y gastric bypass, laparoscopic adjustable gastric banding, laparoscopic sleeve gastrectomy, and biliopancreatic diversion with duodenal switch. Ben discusses their mechanisms, benefits, drawbacks, and potential complications, shedding light on the complexity and consequences of these procedures.

Next, Bikman explores liposuction, highlighting its cosmetic nature and its limited impact on metabolic health. He explains how liposuction removes fat cells from subcutaneous fat depots, which may lead to a rebound effect as remaining fat cells compensate by hypertrophying.

The lecture’s focus then shifts to lifestyle changes, particularly exercise and nutrition. Bikman emphasizes that exercise should be pursued for health and strength rather than solely for weight loss. He stresses the importance of nutrition in fat loss, advocating for strategies that prioritize lowering insulin levels through carbohydrate control, prioritizing protein, and not fearing dietary fat.

Bikman underscores the significance of managing insulin levels as a primary step in fat loss, followed by potential calorie control through structured fasting if necessary. He discusses the metabolic advantages of lowering insulin, including increased metabolic rate and ketone production.

Finally, Dr. Bikman briefly mentions alternate methods like sauna and cold plunge therapy, suggesting their potential contribution to fat loss, although empirical evidence is lacking. He concludes by emphasizing the importance of shrinking fat cells through proper lifestyle strategies, promoting overall metabolic health.

Throughout the lecture, Bikman’s teaching style is engaging and informative, providing insights into the complex interplay of hormones, physiology, and behavior in fat metabolism and weight management. 

Learn more at: https://www.insuliniq.com

Don't forget to like, share, and subscribe for more insightful lectures from Professor Ben Bikman in the Metabolic Classroom series!

Hosted on Acast. See acast.com/privacy for more information.

In this episode of the metabolic classroom, Dr. Ben Bikman takes the helm to explore the multifaceted role of fat tissue as an endocrine organ. He begins by challenging the conventional view of fat tissue as merely a storage depot for energy, emphasizing its crucial role in hormone production and regulation.

Dr. Bikman introduces the concept of endocrine organs and highlights the often overlooked status of fat tissue as one such organ. He discusses how fat tissue releases hormones into the bloodstream, exerting significant metabolic effects throughout the body.

The lecture delves into sex-specific differences in fat distribution and hormone production, with a focus on the influence of estrogen on fat storage and hormone levels in women. Dr. Bikman further explores the impact of menopause on fat tissue and hormonal changes, shedding light on how shifts in hormone production affect metabolism and fertility.

Leptin, the first discovered fat-derived hormone, is dissected in detail by Dr. Bikman, who elucidates its role in appetite regulation, metabolic processes, and fertility. He discusses how excess fat can lead to leptin resistance, compromising its effectiveness in metabolic regulation.

Other hormones such as adiponectin, estrogen, TNF alpha, plasminogen activator inhibitor 1 (PAI-1), and T3 are also explored for their metabolic effects and their association with fat cell size.

The lecture concludes with a focus on brown adipose tissue and its production of T3, highlighting its role in regulating metabolic rate, particularly in response to stimuli like cold exposure.

In summary, Dr. Bikman provides a comprehensive overview of the endocrine functions of adipose tissue, emphasizing the intricate relationship between fat cells and hormone regulation, with implications for metabolism, inflammation, and overall health.

00:01 - Introduction to Adipose Tissue as an Endocrine Organ

01:07 - Sex-Specific Differences in Fat Distribution

03:21 - Impact of Menopause on Fat Tissue and Hormone Production

05:45 - Endocrine Effects of Fat Distribution

07:58 - Role of Fat Tissue in Aromatization and Estrogen Production

10:13 - Impact of Fat Cell Size on Hormone Production

12:24 - Detailed Exploration of Leptin

14:45 - Examination of Adiponectin and its Metabolic Effects

18:17 - TNF Alpha and its Impact on Inflammation and Insulin Resistance

21:05 - Plasminogen Activator Inhibitor 1 (PAI-1) and its Implications for Clotting

22:16 - Brown Adipose Tissue and its Production of T3

24:30 - Conclusion and Summary

#insulinresistance #metabolicsyndrome #metabolichealth #type2diabetes #type1diabetes #weightloss #intermittentfasting #intermittantfasting #fasting #lowcarb 

Learn more at: https://www.insuliniq.com

Hosted on Acast. See acast.com/privacy for more information.

In this episode of The Metabolic Classroom, Professor Ben Bikman, a biomedical scientist specializing in diabetes, metabolism, and fat tissue, delves deeper into the topic of fat tissue, focusing specifically on its storage locations and the factors influencing them.

Dr. Bikman emphasizes the complexity and nuance of fat tissue beyond its commonly recognized role in energy storage, insulation, and cushioning, highlighting its function as an endocrine organ that produces various hormones and signals.

Ben begins by discussing the enzyme lipoprotein lipase (LPL), which plays a crucial role in fat storage by pulling fats off circulating triglyceride-rich lipoproteins in the bloodstream. He explains how the expression and activity of LPL are influenced by factors such as insulin, exercise, and sex hormones, particularly testosterone and estrogen.

The lecture explores how sex differences play a significant role in fat storage patterns, with males tending to store fat centrally around the abdomen due to increased LPL expression induced by testosterone, while females typically store more fat in subcutaneous depots such as the breasts, buttocks, and hips, influenced by estrogen. Ben also discusses the impact of menopause on fat storage, noting shifts towards central fat deposition in women as estrogen levels decline.

Additionally, Dr. Bikman touches on the effects of aging on fat storage, explaining how fat cell number tends to plateau in adulthood and decrease in older age, leading to hypertrophy (enlargement) of existing fat cells and potentially ectopic fat deposition in organs like the liver and pancreas.

The lecture concludes with Ben addressing the difference between hyperplasia (increased fat cell number) and hypertrophy (increased fat cell size) in subcutaneous and visceral fat depots, emphasizing the metabolic implications of storing fat in different locations. He also briefly mentions the influence of non-caloric signals, such as chemicals leached from plastics, on fat cell growth.

Overall, the lecture provides a comprehensive overview of the multifaceted nature of fat tissue storage, highlighting the interplay of hormonal, physiological, and environmental factors in shaping fat distribution and its metabolic consequences.

Hosted on Acast. See acast.com/privacy for more information.

In this week's episode of the Metabolic Classroom, Dr. Bikman delves into the complexities of fat tissue. The lecture aims to shift perspectives on fat beyond mere energy storage, highlighting its multifaceted roles in the body. Dr. Bikman encourages listeners to not only absorb the information but also become teachers themselves, spreading these insights and implementing practical changes.

The lecture begins with an exploration of the evolutionary role of fat, debunking misconceptions and emphasizing its importance in survival and early development. Dr. Bikman discusses theories like the expensive tissue hypothesis, shedding light on why humans are born with fat and its significance in brain growth.

Moving on, Dr. Bikman dives into the different types of fat and their storage mechanisms. He explains the distinctions between subcutaneous and visceral fat, emphasizing their impact on metabolic health. Additionally, he explores the metabolic behavior of fat tissue, distinguishing between white, brown, and beige fat and their implications for energy expenditure and storage.

The lecture concludes with a discussion on the genetic and environmental factors influencing fat storage. Dr. Bikman highlights the role of insulin and energy availability in fat accumulation, as well as the impact of diet and environmental chemicals. By understanding these factors, listeners gain insights into managing weight and promoting metabolic health. Until next time in the Metabolic Classroom, Dr. Bikman reminds his audience: more knowledge, better health.

#insulinresistance #metabolicsyndrome #metabolichealth #type2diabetes #type1diabetes #weightloss #intermittentfasting #intermittantfasting #fasting 

Learn more at: https://www.insuliniq.com

Hosted on Acast. See acast.com/privacy for more information.

In this week's episode of the Metabolic Classroom, Dr. Ben Bikman welcomes viewers to a discussion on commonly used cardiometabolic and weight loss drugs. The focus of this particular lecture is on drugs targeting heart disease, a leading cause of mortality globally. Dr. Bikman acknowledges the controversy surrounding cardiovascular drugs due to the severity of heart disease and the passionate advocacy for drug therapies.

The lecture begins with an overview of two main categories of cardiovascular drugs: those addressing blood pressure and those targeting cholesterol levels. Dr. Bikman explains the significance of blood pressure in cardiovascular health, emphasizing its correlation with heart attacks and hypertension. He delves into the physiological effects of high blood pressure, likening it to over-inflating a balloon and causing stress and damage to the inner lining of blood vessels.

Moving on to drugs that control blood pressure, Dr. Bikman highlights the potential impact on insulin resistance and mitochondrial function, crucial factors in heart disease risk. He discusses common classes of antihypertensive drugs such as beta blockers, ACE inhibitors, calcium channel blockers, and diuretics, detailing their mechanisms and side effects.

Transitioning to cholesterol-lowering drugs, Dr. Bikman discusses the controversy surrounding the assumption that cholesterol is solely responsible for heart disease. He challenges the oversimplified view of LDL cholesterol's role in plaque formation and suggests alternative paradigms, including the immune response to infections in blood vessels.

Dr. Bikman then discusses two classes of anti-cholesterol medications: PCSK9 inhibitors and statins. He explains how PCSK9 inhibitors increase LDL receptor expression to enhance LDL clearance and discusses potential side effects such as worsened insulin resistance and mitochondrial dysfunction. Finally, he explores the mechanism of statins in reducing cholesterol production and addresses controversies surrounding their use, including potential risks of developing type 2 diabetes and Alzheimer's disease.

#insulinresistance #metabolicsyndrome #metabolichealth #type2diabetes #type1diabetes #weightloss #intermittentfasting #intermittantfasting #fasting #lowcarb 

Learn more at: Insulin IQ

Hosted on Acast. See acast.com/privacy for more information.

In today's lecture, Dr. Bikman guides his audience through a comprehensive exploration of anti-diabetic drugs, shedding light on their mechanisms, implications, and the broader context of diabetes management. Kicking off the discussion, Dr. Bikman elucidated the prevalent glucose-centric paradigm in understanding diabetes, emphasizing its limitations, particularly in discerning the nuanced differences between type 1 and type 2 diabetes. He underscored the pivotal role of insulin deficiency in type 1 and insulin resistance in type 2 diabetes, setting the stage for a deeper dive into the intricacies of anti-diabetic medications.

The lecture commenced with an in-depth analysis of metformin, a cornerstone in diabetes treatment known for its efficacy in improving insulin sensitivity. Despite its widespread use, Dr. Bikman elucidated the persistent ambiguity surrounding metformin's cellular mechanisms, particularly concerning its impact on mitochondrial function. While acknowledging its beneficial effects, such as reducing hepatic glucose production, Dr. Bikman also highlighted the drug's gastrointestinal side effects and its potential to blunt mitochondrial adaptations to exercise.

Transitioning to insulin therapy, Dr. Bikman delineated its indispensable role in type 1 diabetes management but cautioned against its potential risks in type 2 diabetes, including weight gain and heightened cardiovascular, cancer, and Alzheimer's disease risks. He delved into the nuances of insulin secretagogues and thiazolidinediones, discussing their mechanisms and associated complications, such as increased cardiovascular risk and adverse effects on adipogenesis.

Further, Dr. Bikman explored GLP-1 agonists and SGLT2 inhibitors, elucidating their mechanisms of action and potential side effects, including an elevated risk of urinary tract infections with SGLT2 inhibitors and heightened ketogenesis. Before concluding, he briefly touched on amylin analogs, adding another dimension to the multifaceted landscape of anti-diabetic medications.

Dr. Bikman's lecture provided a comprehensive understanding of anti-diabetic drugs, transcending the traditional glucose-centric perspective and highlighting the complexities inherent in diabetes management. By navigating through the intricate mechanisms and implications of these medications, he empowered his audience with invaluable insights to navigate the complexities of diabetes treatment effectively.

#insulinresistance #metabolicsyndrome #metabolichealth #type2diabetes #type1diabetes #weightloss #intermittentfasting #intermittantfasting #fasting 

Learn more at: https://www.insuliniq.com

Hosted on Acast. See acast.com/privacy for more information.

In today's episode of The Metabolic Classroom, Dr. Ben Bikman delves into the fascinating topic of GLP-1, a hormone of significant interest in metabolic research. Dr. Bikman sets the stage by expanding the discussion beyond GLP-1 to include other incretions, defining them as a class of hormones produced by the small intestine. These hormones play crucial roles in nutrient metabolism, satiety, and hunger regulation.

The discovery of incretions stemmed from observations following gastric bypass surgeries, where elevated levels of these hormones were found in the bloodstream, leading to improvements in diabetes. Dr. Bikman highlights GLP-1's well-known effect on insulin secretion and glucagon suppression, which contribute to its ability to rapidly correct high glucose levels and improve diabetes. However, he notes the ongoing debate regarding GLP-1's direct insulin secretagogue effect in humans, contrasting findings from cell culture and animal models with recent human studies.

Moving beyond GLP-1, Dr. Bikman discusses other incretions like GIP, PYY, and cholecystokinin, outlining their roles in glucose regulation, appetite control, and digestion. He explores the pharmacological applications of GLP-1 agonists in managing diabetes and obesity, detailing various drugs and their mechanisms of action. Furthermore, he touches upon natural methods to enhance GLP-1 secretion, including dietary factors like protein, fat, and sugars. The session concludes with insights into the live Q&A session, emphasizing the dynamic interaction between science and audience participation in The Metabolic Classroom.

Learn more at: https://www.insuliniq.com 

Hosted on Acast. See acast.com/privacy for more information.

Beginning with a discussion on the evolution of these medications, Dr. Bikman emphasizes their significance in combating obesity-related health issues. He proceeds to analyze the mechanisms of popular weight loss drugs, such as Orlistat, Phentermine, and the combination of Phentermine with Topiramate, elucidating how each functions to aid weight loss.

While highlighting the benefits, Dr. Bikman doesn’t shy away from detailing the potential side effects, ensuring a comprehensive understanding for the audience. Moreover, he shares an intriguing scientific fact regarding lactate’s role in fat metabolism, adding depth to the discussion. Throughout, Dr. Bikman maintains a balance between scientific evidence and personal insight, fostering an engaging and informative session.

In discussing liraglutide’s mechanism of action, Dr. Bikman reveals its role as a GLP-1 receptor agonist, mimicking the actions of the incretin GLP-1. He then previews next week’s class dedicated to incretins and their use in weight loss drugs, including medications like wegovy and ozempic.

Liraglutide primarily promotes weight loss by reducing gastric emptying, leading to prolonged feelings of fullness and decreased appetite. Additionally, it inhibits glucagon, lowering blood glucose levels and subsequently increasing metabolic rate and fat burning. Dr. Bikman notes common side effects such as gastrointestinal discomfort and hints at potential risks of thyroid tumors associated with GLP-1 agonists.

Ben transitions to discussing semaglutide, another GLP-1 receptor agonist, and its similar effects on weight loss and side effects, including the possibility of ileus. He also touches on metformin’s off-label use for weight loss, its mechanisms involving AMPK activation and ATP inhibition, and its potential interference with exercise-induced mitochondrial benefits.

Learn more at: Insulin IQ

Hosted on Acast. See acast.com/privacy for more information.

In today's Metabolic Classroom, the discussion centers on addressing insulin resistance, marking the final part of a series that viewers are encouraged to catch up on if they haven't already. Previous episodes have delved into the nature, origins, and implications of insulin resistance, highlighting its association with various diseases. Despite the somber tone of these revelations, the current discussion offers a ray of hope by focusing on solutions to this pervasive issue, emphasizing its solvability and preventability.

Before delving into strategies for combating insulin resistance, Dr. Bikman takes a moment to outline methods for assessing one's own insulin resistance status, recognizing limitations in traditional approaches that solely focus on glucose levels. He stresses the importance of understanding insulin's broader role beyond glucose regulation, highlighting the significance of elevated insulin levels as an early indicator of resistance. The discussion moves to practical considerations, such as interpreting fasting insulin levels, with values below six suggesting insulin sensitivity, while higher readings may indicate varying degrees of resistance, requiring further evaluation.

Learn more: https://www.insuliniq.com

Hosted on Acast. See acast.com/privacy for more information.

The focus of Dr. Bikman’s Metabolic Classroom today is to help us all better understand, “Why does insulin resistance matter?”

This week's Metabolic Classroom with Dr. Bikman delves into insulin resistance and its impact on health. Insulin resistance, involving impaired insulin function and elevated blood insulin levels, is explored as a key factor in chronic diseases. Dr. Bikman focuses on its crucial role in connecting obesity and type two diabetes, examining its effects on muscle tissue, the liver, and pancreatic alpha cells.

The delayed diagnosis of type two diabetes, due to a focus on glucose levels, is highlighted, with Dr. Bikman discussing the ongoing debate about which tissues become insulin resistant first. The complexities of insulin resistance in fat cells, muscles, the liver, and alpha cells of the pancreas are underscored.

Insulin resistance's effects on glucose clearance in muscle tissue and disruptions in the liver's glycogen storage and glucose regulation are explained. The discussion expands to its impact on pancreatic alpha cells, contributing to elevated blood glucose levels. Dr. Bikman explores the connection between insulin resistance and various health issues, including type 2 diabetes, fatty liver disease, Alzheimer's, hypertension, and infertility.

In examining these health conditions, Dr. Bikman challenges conventional views and emphasizes the role of insulin resistance. For instance, Alzheimer's is linked to metabolic factors, while hypertension is connected to insulin-driven mechanisms. The discussion also covers the influence of insulin resistance on infertility, affecting both erectile dysfunction and polycystic ovary syndrome (PCOS).

Dr. Bikman concludes by summarizing how insulin resistance influences these health conditions and highlights lifestyle modifications as a positive intervention. The upcoming discussion on clinically measuring insulin resistance and actionable steps is teased, urging viewers to share this knowledge for broader awareness.

Learn more at: Insulin IQ

Hosted on Acast. See acast.com/privacy for more information.

The focus of the classroom today is to help you better understand the origins of insulin resistance.

Learn more at: Insulin IQ

Hosted on Acast. See acast.com/privacy for more information.

The title for today is focusing on Insulin Resistance in the Metabolic Syndrome, and I could describe that another way, which is just kind of understanding metabolic health and that’s at the heart of what I wanted to focus on for the time that we have during the lesson itself.

Alright, so first of all, metabolic health. We’ve all heard the term metabolism a lot. It is a buzzword, it is a word that we hear perhaps too often and even to the point that it’s often misused. 

Metabolism, just to be very precise, is the balance of all of the chemical reactions that are happening in the body. There are biochemical reactions in every cell that are trying to build up molecules. Those are called anabolic reactions or anabolism, and there are chemical biochemical processes that are degrading molecules, breaking them down. That is catabolism and metabolism is the fusion or the balance of all of those things. The sum of all of those reactions.

Now with metabolic health, we’re starting to get more specific to the topic.

Learn more at: Insulin IQ

Hosted on Acast. See acast.com/privacy for more information.

Many people today are wary of discussions about leaky gut because there are so many questionable cures being sold without scientific evidence to support them. Let's talk about exactly what leaky gut is and how it's affected by what we eat.

Here are the resources that Ben references during the episode:

Source #1 - https://pubmed.ncbi.nlm.nih.gov/18000291/

Source #2 - https://aasldpubs.onlinelibrary.wiley.com/doi/full/10.1002/hep.30652

Source #3 - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412740/

Source #4 - https://science.sciencemag.org/content/373/6553/eabe6729

Source #5 - https://pubmed.ncbi.nlm.nih.gov/27171436/

Learn more at Insulin IQ

Hosted on Acast. See acast.com/privacy for more information.

One of the most persistent oppositions to a low carb diet is the idea that it can damage the kidneys. Let's dive into what the data really shows.

Here is the resource that Ben references during the episode:

Source #1 - https://pubmed.ncbi.nlm.nih.gov/30383278/

Source #2 - https://pubmed.ncbi.nlm.nih.gov/27346534/

Learn more at Insulin IQ

Hosted on Acast. See acast.com/privacy for more information.

Many people claim that eating low-carb can actually make you insulin resistant. How can this be? The answer lies in the key difference between two types of insulin resistance; pathological versus physiological. Let's discuss what's really happening.

Here is the resource that Ben references during the episode:

Source #1 - https://academic.oup.com/jes/article/5/5/bvab049/6199842?login=true

Learn more at Insulin IQ

Hosted on Acast. See acast.com/privacy for more information.

It’s estimated that up to 12% of women in the US are affected by fertility problems directly caused by insulin resistance. Join Dr. Ben Bikman, the Insulin IQ team, and special guest Dr. Steven Cowles, OBGYN, for a conversation on how insulin control is giving women hope to have the family they want.

Here is the resource that Ben references during the episode:

Source #1 - https://pubmed.ncbi.nlm.nih.gov/26225266/

Learn more at Insulin IQ

Hosted on Acast. See acast.com/privacy for more information.

Here are the resources that Ben references during the episode:

Study #1 - https://care.diabetesjournals.org/content/25/2/364.short

Learn more at Insulin IQ

Hosted on Acast. See acast.com/privacy for more information.

For our entire lives we’ve always heard that “healthy whole grains are an essential part of a balanced diet.” In light of what we now know about nutrition and insulin, does that statement hold up? Join Dr. Bikman and the Insulin IQ team for a conversation about the evidence.

Here are the resources that Ben references during the episode:

Study #1 - https://www.sciencedirect.com/science/article/abs/pii/0002934387900581?via%3Dihub

Study #2 - https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1651-2227.1987.tb10498.x

Study #3 - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325021/

Study #4 - https://cdnsciencepub.com/doi/full/10.4141/cjas2012-017

Study #5 - https://academic.oup.com/ajcn/article/103/2/341/4564756?login=true

BYU Address - https://speeches.byu.edu/talks/benjamin-bikman/the-plagues-of-prosperity/

Learn more at Insulin IQ

Hosted on Acast. See acast.com/privacy for more information.

Some of the most common diabetes drugs work in interesting ways. Let’s talk about some of the most common: SGLT inhibitors and GLP-1 receptor agonists.

Here are the resources that Ben references during the episode:

Study #1 - https://pubmed.ncbi.nlm.nih.gov/24917578/

Study #2 - https://pubmed.ncbi.nlm.nih.gov/30240793/

Study #3 - https://pubmed.ncbi.nlm.nih.gov/32827151/

Learn more at Insulin IQ

Hosted on Acast. See acast.com/privacy for more information.

“Good” cholesterol? “Bad” cholesterol? Decades of unclear and misinterpreted science have led to widespread misunderstanding of this vital component of every cell in our bodies. Join Dr. Ben Bikman, special guest Dr. Bret Scher, and the Insulin IQ team as we distill down what you need to know about cholesterol.

Learn more at Insulin IQ

Hosted on Acast. See acast.com/privacy for more information.

Despite sharing a name, type 1 and type 2 diabetes have surprisingly little in common. Let’s explore what they have in common and their many differences.

Here are the resources that Ben references during the episode:

Study #1 - https://www.endocrinology.org/endocrinologist/129-autumn18/features/endogenous-insulin-its-role-in-the-initiation-progression-and-management-of-diabetes

Learn more at Insulin IQ

Hosted on Acast. See acast.com/privacy for more information.

Metformin is the most widely used drug to fight diabetes. Let’s talk about how it works and when it doesn’t work well.

Here are the resources that Ben references during the episode:

Study #1 - https://www.sciencedirect.com/science/article/abs/pii/S0891584910003874?casa_token=z96rcmkuc7YAAAAA:pxbbTkuPhL7Nop4oUECKmCq81Ev4Dc7z4XYvbaNMXLorp-F9p4nrHLo9bkUiIL0Trjv9EhNNGds

Study #2 - https://www.jci.org/articles/view/13505?content_type=full

Study #3 - https://europepmc.org/article/med/3817257

Study #4 - https://onlinelibrary.wiley.com/doi/full/10.1111/acel.13039

Study #5 - https://onlinelibrary.wiley.com/doi/full/10.1111/acel.12880

Learn more at Insulin IQ

Hosted on Acast. See acast.com/privacy for more information.

A spike in glucose levels each morning can be startling, but it doesn’t need to be scary. To understand the dawn phenomenon, you need to understand hormones.

Here are the resources that Ben references during the episode:

Study #1 - https://www.nejm.org/doi/full/10.1056/nejm198811103191901

Study #2 - https://pubmed.ncbi.nlm.nih.gov/6389230/

Study #3 - https://pubmed.ncbi.nlm.nih.gov/2859524/

Study #4 - https://diabetes.diabetesjournals.org/content/45/8/1044

Learn more at Insulin IQ

Hosted on Acast. See acast.com/privacy for more information.

Stress is an essential part of being human—we need a stress response. However, when stress is turned on indefinitely, metabolic health suffers.

Learn more at Insulin IQ

Hosted on Acast. See acast.com/privacy for more information.

Sex hormones control many processes in the body and estrogens have multiple and diverse effects on telling the body where and how to store fat.

Learn more at Insulin IQ

Hosted on Acast. See acast.com/privacy for more information.

We all know about leptin’s effects on hunger, but it’s involved in so much more. Let’s learn about this metabolic heavyweight.

Learn more at Insulin IQ

Hosted on Acast. See acast.com/privacy for more information.

Dietary fiber enjoys a lofty position in the hallowed halls of dietary advice, but the truth is more complicated. Whether fiber is helpful or harmful depends on other factors.

Here are the resources that Ben references during the episode:

Study #1 - https://academic.oup.com/ajcn/article-abstract/59/6/1386/4715907

Study #2 - https://pubmed.ncbi.nlm.nih.gov/6259919/

Study #3 - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3435786/

Learn more at Insulin IQ

Hosted on Acast. See acast.com/privacy for more information.

The brain is among the highest metabolic rate organs in the body. It needs a lot of energy, and it needs insulin’s help. When the brain becomes insulin resistant, we create an “energy gap” that stems from a genetic level.

Here are the resources that Ben references during the episode:

Study #1 - https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0144116

Study #2 - https://pubmed.ncbi.nlm.nih.gov/25147107/

Study #3 - https://alz-journals.onlinelibrary.wiley.com/doi/full/10.1002/alz.12310

Learn more at Insulin IQ

Hosted on Acast. See acast.com/privacy for more information.

Within the field of nutrition, fewer topics are as hotly debated and defended as the view that red meat causes cancer. Let’s explore the data, keeping in mind that correlation is not causation.

Learn more at Insulin IQ

Hosted on Acast. See acast.com/privacy for more information.

How glucose moves in and out of cells is important to understanding insulin resistance, fuel use, and more. Let’s learn about glucose transporters on cells and how they regulate glucose in the body.

Learn more at Insulin IQ

Hosted on Acast. See acast.com/privacy for more information.

We’ve been told for decades that saturated fats cause plaques that block blood vessels. What if that’s wrong?

Study #1 - https://www.pnas.org/content/76/1/333.short

Study #2 - https://www.cell.com/fulltext/S0092-8674(00)81574-3#BIB40

Study #3 - https://pubmed.ncbi.nlm.nih.gov/9488997/

Study #4 - https://www.plefa.com/article/S0952-3278(12)00146-9/pdf

Study #5 - https://www.bmj.com/content/bmj/346/bmj.e8707.full.pdf

Study #6 - https://www.bmj.com/content/353/bmj.i1246

Learn more at Insulin IQ

Hosted on Acast. See acast.com/privacy for more information.

While a calorie is certainly a calorie, overlooking the effect of those calories on insulin means we miss a piece of the metabolic puzzle. We’ll explore some studies that reveal what insulin does to metabolic rate in the body.

Learn more at Insulin IQ

Hosted on Acast. See acast.com/privacy for more information.

A low-carb diet can do a lot of good things, but does it come at the expense of the thyroid? We’ll review the evidence and explore the relationship between thyroid and carbs.

Here are the resources that Ben references during the episode:

Study #1 - https://pubmed.ncbi.nlm.nih.gov/11167929/

Study #2 - https://pubmed.ncbi.nlm.nih.gov/6865775/

Learn more at Insulin IQ

Hosted on Acast. See acast.com/privacy for more information.

When fat cells get too big rather than too many, they start to suffer. This week Dr. Ben Bikman and the Insulin IQ Team review the evidence for why this happens and what you can do about it.

Here are the resources that Ben references:

Source #1 - https://jim.bmj.com/content/64/5/989

Source #2 - https://pubmed.ncbi.nlm.nih.gov/30649347/

Source #3 - https://pubmed.ncbi.nlm.nih.gov/32398753/

Learn more at Insulin IQ

Hosted on Acast. See acast.com/privacy for more information.

Are you worried about your fatty liver. This week Dr. Ben Bikman and the Insulin IQ Team explore what the sweet carbohydrate, fructose, does to liver fat.

Here are the three studies that Ben references during this session:

Source - #1 https://academic.oup.com/ajcn/advance-article/doi/10.1093/ajcn/nqaa332/6056215?fbclid=IwAR3K6hXW-NlQFWUdsnr0RcQuzgSatgJEosx_8Q3gE79VFL-XkLkYldeRD-c

Source - #2 - https://www.jci.org/articles/view/37385/figure/1

Source #3 - https://pubmed.ncbi.nlm.nih.gov/25825943/

Learn more at Insulin IQ

Hosted on Acast. See acast.com/privacy for more information.

Are you eating enough salt to stay insulin sensitive? Dietary salt is too often viewed as something to avoid, but could eating too little salt actually make your metabolic problems worse? Dr. Ben Bikman and the Insulin IQ Team discuss what you need to know.

Here is the link referenced in this episode:

Source #1 - https://pubmed.ncbi.nlm.nih.gov/9589654/

Learn more at Insulin IQ

Hosted on Acast. See acast.com/privacy for more information.

Long term restriction of calories seems like the simplest answer to losing weight; eat less weigh less, right? However, this approach the serious consequences that chronic calorie restriction has on your fat cells and hormones. This week Dr. Ben Bikman and the Insulin IQ Team explain the metabolic reasons why getting healthier is not just about calories.

Here is the link referenced in this episode:

Source #1 - https://pubmed.ncbi.nlm.nih.gov/3308961/

Learn more at Insulin IQ

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

Do low-carb diets spike cortisol and reduce muscle mass? The stress hormone cortisol is not something we want elevated for very long. If you've heard that a low-carb diet spikes cortisol levels, you may be concerned. This week Dr. Ben Bikman and the Insulin IQ team dive into a couple of studies on this important topic.

Hosted on Acast. See acast.com/privacy for more information.

At Insulin IQ, we get lots of questions from our clients and students about low-carb, high-fat eating and the thyroid.

In this episode of Dr. Bikman’s Metabolic Classroom, Ben discusses this topic with a couple of our Insulin IQ team members.

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

Our friend, Dr. Bret Scher, MD writes, “A new study, published in the Journal of the American Medical Association (JAMA), shows no benefit from intermittent fasting. But, after taking a close look, it’s revealed that we should be cautious about how we interpret this conclusion.”

During our Insulin IQ LIVE stream on Monday, October 5, 2020 Dr. Ben Bikman shares his thoughts on the JAMA research.

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.